These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7153306)

  • 41. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents.
    Parry NR; Barnett PV; Ouldridge EJ; Rowlands DJ; Brown F
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1493-503. PubMed ID: 2471812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunoreactivity of human and rabbit antisera to hepatitis A virus.
    Gauss-Müller V; Deinhardt F
    J Med Virol; 1988 Feb; 24(2):219-28. PubMed ID: 2832540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the human cytomegalovirus envelope glycoproteins.
    Farrar GH; Oram JD
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():1991-2001. PubMed ID: 6094713
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterisation of rubella virus hemagglutinin rosettes.
    Trudel M; Marchessault F; Payment P
    J Virol Methods; 1981 Mar; 2(4):195-201. PubMed ID: 7228976
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Presence of DNA in rubella variant with DNA polymerase activity.
    Sato M; Maeda N; Shirasuna K; Yoshida H; Yanagawa T; Yura Y; Miyazaki T
    Arch Virol; 1979; 61(3):251-4. PubMed ID: 496646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural proteins of hand, foot and mouth disease viruses.
    Yoneyama T; Hagiwara A; Tagaya I
    Intervirology; 1980; 13(2):130-2. PubMed ID: 6246027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. E1 glycoprotein of rubella virus carries an epitope that binds a neutralizing antibody.
    Trudel M; Nadon F; Séguin C; Amarouch A; Payment P; Gillam S
    J Virol Methods; 1985 Dec; 12(3-4):243-50. PubMed ID: 2422194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 A.
    Arnold E; Rossmann MG
    J Mol Biol; 1990 Feb; 211(4):763-801. PubMed ID: 2156077
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Localization of rubella virus core particles in vero cells.
    Lee JY; Marshall JA; Bowden DS
    Virology; 1999 Dec; 265(1):110-9. PubMed ID: 10603322
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polyomavirus VP1 phosphorylation: coexpression with the VP2 capsid protein modulates VP1 phosphorylation in Sf9 insect cells.
    Li M; Delos SE; Montross L; Garcea RL
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5992-6. PubMed ID: 7597067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assembly of five bluetongue virus proteins expressed by recombinant baculoviruses: inclusion of the largest protein VP1 in the core and virus-like proteins.
    Loudon PT; Roy P
    Virology; 1991 Feb; 180(2):798-802. PubMed ID: 1846500
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunological characterisation of the rubella E 1 glycoprotein. Brief report.
    Ho-Terry L; Terry GM; Cohen A; Londesborough P
    Arch Virol; 1986; 90(1-2):145-52. PubMed ID: 2425779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and characterization of the virion protein products of herpes simplex virus type 1 gene UL47.
    McLean G; Rixon F; Langeland N; Haarr L; Marsden H
    J Gen Virol; 1990 Dec; 71 ( Pt 12)():2953-60. PubMed ID: 2177087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The major structural proteins of murine mammary tumor virus: techniques for isolation.
    Dion AS; Williams CJ; Pomenti AA
    Anal Biochem; 1977 Sep; 82(1):18-28. PubMed ID: 199080
    [No Abstract]   [Full Text] [Related]  

  • 55. Efficient in vitro translation and processing of the rubella virus structural proteins in the presence of microsomes.
    Marr LD; Sanchez A; Frey TK
    Virology; 1991 Jan; 180(1):400-5. PubMed ID: 1984659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antipeptide antibodies directed against the carboxy-terminal region of SV40 structural proteins VP2 and VP3.
    Streckert HJ; Brüssow H; Sure K; Werchau H
    J Cell Biochem; 1986; 31(4):277-87. PubMed ID: 3020068
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.
    Orvell C; Norrby E; Mufson MA
    J Gen Virol; 1987 Dec; 68 ( Pt 12)():3125-35. PubMed ID: 2447224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recognition of synthetic peptides with sequences of rubella virus E1 polypeptide by antibodies and T lymphocytes.
    Ilonen J; Seppänen H; Närvänen A; Korkolainen M; Salmi AA
    Viral Immunol; 1992; 5(3):221-8. PubMed ID: 1384533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus.
    Bachrach HL; Moore DM; McKercher PD; Polatnick J
    J Immunol; 1975 Dec; 115(6):1636-41. PubMed ID: 171309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential IgG avidity to rubella virus structural proteins.
    Mauracher CA; Mitchell LA; Tingle AJ
    J Med Virol; 1992 Mar; 36(3):202-8. PubMed ID: 1564450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.